Shopping Cart
- Remove All
- Your shopping cart is currently empty
Tofersen (BIIB067) is an antisense oligonucleotide used to inhibit the synthesis of superoxide dismutase 1 (SOD1) protein by facilitating the degradation of SOD1 mRNA via an RNase H-dependent mechanism. This compound holds potential for amyotrophic lateral sclerosis (ALS) research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $623 | Backorder |
Description | Tofersen (BIIB067) is an antisense oligonucleotide used to inhibit the synthesis of superoxide dismutase 1 (SOD1) protein by facilitating the degradation of SOD1 mRNA via an RNase H-dependent mechanism. This compound holds potential for amyotrophic lateral sclerosis (ALS) research. |
In vitro | Tofersen employs antisense oligonucleotides (ASOs) to specifically target SOD1 mRNA through Watson-Crick base pairing, facilitating the activation of RNase H1, which then degrades the targeted RNA[2]. |
Alias | ISIS-SOD1Rx, BIIB067 |
Cas No. | 2088232-70-4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.